Hospital
East Carolina Health-Beaufort INC
East Carolina Health-Beaufort INC was paid $2.38M by Medicaid between Jan 2018 and Sep 2021, across 61 billing codes. Its largest line is 99284, emergency room visit (serious) — 28% of everything it billed.
33Billing provider infoEAST CAROLINA HEALTH-BEAUFORT INC
WASHINGTON, NC 27889
WASHINGTON, NC 27889
33aNPI1679867170assigned 06/02/2011
33bProvider typeGeneral Acute Care Hospital
28Total paid$2.38M
24GClaims75,691
24DCodes billed61
24AFirst – last monthJan 2018 – Sep 2021
Compared with peers
Next to other General Acute Care Hospital providers in North Carolina
Rank by total paid#73 of 92
Median peer was paid$11.47M
This provider vs. median0.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 21,248 | $535K | |
| 2019 | 22,013 | $654K | |
| 2020 | 17,439 | $522K | |
| 2021 | 14,991 | $665K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 28% | 6,512 | 6,204 | $660K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 21% | 7,310 | 7,066 | $489K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 14% | 2,440 | 2,319 | $323K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 6.5% | 1,729 | 1,664 | $154K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 4.2% | 3,109 | 2,936 | $101K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.2% | 12,865 | 10,834 | $76K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.9% | 380 | 364 | $69K |
| 71046 | Radiologic examination, chest; 2 views | 2.8% | 1,691 | 1,644 | $66K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.7% | 2,907 | 2,770 | $63K |
| 80053 | Comprehensive metabolic panel | 2.3% | 8,464 | 7,477 | $55K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.1% | 109 | 107 | $49K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.5% | 1,135 | 1,001 | $37K |
49 more codes
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1.1% | 932 | $26K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 800 | $20K |
| 0225U | <1% | 49 | $17K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 2,030 | $16K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 546 | $15K |
| 81025 | <1% | 2,092 | $14K | |
| 84484 | <1% | 1,693 | $14K | |
| 71045 | Radiologic examination, chest; single view | <1% | 236 | $10K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,305 | $9K |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,806 | $9K |
| 81001 | <1% | 2,671 | $8K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 172 | $7K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 117 | $7K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 337 | $7K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 275 | $6K |
| 81003 | <1% | 2,620 | $5K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 505 | $5K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 49 | $4K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | <1% | 35 | $4K |
| 82728 | <1% | 366 | $4K | |
| 83690 | <1% | 607 | $3K | |
| J3490 | Unclassified drugs | <1% | 682 | $3K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 58 | $3K |
| 84466 | <1% | 283 | $3K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 245 | $2K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 81 | $2K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 280 | $2K |
| 83540 | <1% | 350 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 342 | $1K |
| V2632 | Posterior chamber intraocular lens | <1% | 43 | $966.00 |
| 20610 | <1% | 73 | $828.11 | |
| 87430 | <1% | 61 | $785.40 | |
| 83605 | <1% | 69 | $656.94 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 354 | $614.63 |
| 87088 | <1% | 81 | $484.09 | |
| 83735 | <1% | 92 | $480.18 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 379 | $438.24 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 12 | $344.96 |
| 83550 | <1% | 53 | $317.60 | |
| 85027 | <1% | 29 | $207.80 | |
| 87070 | <1% | 20 | $182.41 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 12 | $157.40 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 65 | $149.50 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 32 | $146.85 |
| 87040 | <1% | 18 | $128.60 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 29 | $96.55 |
| 85007 | <1% | 29 | $95.52 | |
| 87081 | <1% | 13 | $86.16 | |
| 82962 | <1% | 12 | $37.48 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTAYLOR, MICHELLE (CFO)
| Provider | Location | Paid |
|---|---|---|
| Abl Medical Care LLC | Winter Springs, FL | $1.08M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.